Abbott Header Logo
Logo Image

ALINITY m RESP-4-PLEX ASSAY*

*For In Vitro Diagnostic Use.

ALINITY m RESP-4-PLEX ASSAY
ALINITY m RESP-4-PLEX ASSAY
ALINITY m RESP-4-PLEX ASSAY

Innovative multiplex SARS-CoV-2, flu A, flu B, and RSV assay to curb the COVID-19 outbreak during flu season.  The Alinity m Resp-4-Plex assay offers workflow efficiency and high throughput solution the laboratory requires today to meet the public health need for differentiation of all 4 viruses. (Learn about SARS-CoV-2 variant detection, click here)

  • Improved Operational Efficiencies
    • Streamlined workflow with primary sample loading provides operational efficiencies allowing laboratories to process increased test volumes with existing lab staff and limited resources
  • Leading Science - Providing Confidence in Results
    • Single test with multiplex assay design to differentiate between SARS-CoV-2, flu A, flu B, and RSV and help diagnose infection by one of the viruses
    • High sensitivity assay to detect individuals with low viral load

INTENDED USE

The Alinity m Resp-4-Plex assay is a multiplex real-time reverse transcription (RT) polymerase chain reaction (PCR) test intended for the qualitative detection and differentiation of RNA from influenza A virus (flu A), influenza B virus (flu B), Respiratory Syncytial Virus (RSV), and SARS-CoV-2 in nasopharyngeal (NP) swab specimens collected by a healthcare provider, from individuals with signs and symptoms of respiratory tract infection.


Results are for the identification and differentiation of RNA from flu A, flu B, RSV, and SARS-CoV-2. flu A, flu B, RSV, and SARS-CoV-2 RNA are generally detectable in nasopharyngeal swab specimens during the acute phase of infection. Positive results are indicative of the presence of flu A, flu B, RSV, or SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease.

The Alinity m Resp-4-Plex assay is not intended to detect influenza C virus infections.

Negative results do not preclude flu A, flu B, RSV, or SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information.

The Alinity m Resp-4-Plex assay is intended for use by qualified and trained clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures.

INTENDED USER

The intended users for the Alinity m Resp-4-Plex assay are laboratory professionals.

 

ABBOTT ALINITY m RESP-4-PLEX ASSAY SPECIFICATIONS1-4
TechnologyQualitative multiplex real-time reverse transcription PCR
Time to first< 120 min time to first result
ThroughputUp to 1008 samples in 24 hours (number of actual samples per 24-hour period may vary based on laboratory practice and workflow)
Assay DesignMultiplex assay to detect Flu A virus, Flu B virus, RSV and SARS-CoV-2
Target RegionRdRp and N-gene of the SARS-CoV-2 genome, Matrix gene of the flu A genome, Nonstructural 1 gene of the flu B genome, Matrix gene of the RSV genome 
Limit of DetectionSARS-CoV-2: 30 GC/mL
Flu A: 0.002 TCID50/mL; 0.06 TCID50/mL*
Flu B: 0.020 TCID50/mL; 0.050 TCID50/mL*
RSV: 0.300 TCID50/mL; 0.100 TCID50/mL*
*Depending on strain
Specimen TypesNasopharyngeal swabs 
Result InterpretationCycle number/not detected
Minimum Sample Volume Depending on tube between 0.8 mL and 1.4 mL.
ControlsNegative and positive control
Internal ControlArmored RNA, added to each specimen and control

1. Alinity m Resp-4-Plex AMP Kit Package Insert: 53-608209/R4  2. Alinity m Resp-4-Plex Control Kit Package Insert: 53-608212/R2.   3. Alinity m Operations Manual: 54-605001/R15.  4. Abbott Data on File

Logo Image

© 2025 Abbott, Abbott Park, Illinois, U.S.A.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. Other trademarks are the property of their respective owners.

This Internet site that you have requested is intended for the residents of a particular country or countries and may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions. If you are a resident of a country other than those to which this site is directed, contact your local Abbott affiliate to obtain the appropriate product information for your country of residence.

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

DO YOU WISH TO CONTINUE AND ENTER THIS WEBSITE?

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

DO YOU WISH TO CONTINUE AND ENTER THIS WEBSITE?